BsUFA Revenue Missed Estimates Again In FY2019

Spending Reduced To Account For Shortfall

US FDA said that total BsUFA obligations also decreased compared to estimates, but maintains optimism about future revenue increases.

Money Wave
Estimates of future BsUFA revenue indicate substantial increases compared to FY2019 collections • Source: Shutterstock

More from Biosimilars

More from Products